Buy MRK Merck being a Pharma company which belongs to a defensive sector is a good buy around 69$ levels. Has a P/E of less 10 and dividend of 4% at current price can be a good long term hold who targets passive income with dividend.
For swing trade , buying at 69-70 levels and target 20% to sell at 85 lev
1.25 USD
15.20 B USD
56.82 B USD
About Merck & Company, Inc.
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
ISIN
ARDEUT110277
FIGI
BBG000FT0R36
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Merck Wave Analysis – 19 May 2025
- Merck reversed from support area
- Likely to rise to resistance level 80.00
Merck recently reversed up from the support area between the long-term support level 73.35 (which has been reversing the price from the middle of 2020) and the lower weekly Bollinger Band.
The upward reversal from this
Merck & Company Potential Post Tariff Resolution Bullish RallyWith potential developments towards the resolution of global tariffs and pharma being defensive in general, MRK price action seems to exhibit signs of a potential Bullish reversal breakout as the price action may form a prominent Higher High with multiple confluences through key Fibonacci and Suppor
Is MRK Setting Up for a Major Comeback? 🧬Merck & Co. (MRK) is trading around $81.00 down significantly from its 52-week high of $134.63 but this pullback could be your window of opportunity. With a solid forward P/E of 9.02, a 3.9% dividend yield, and a pipeline packed with over 20 potential blockbuster drugs, the fundamentals remain str
MERCK Stock Chart Fibonacci Analysis 042525Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 82/61.80%
Chart time frame: D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
E
MRK Merck Options Ahead of EarningsAnalyzing the options chain and the chart patterns of MRK Merck prior to the earnings report this week,
I would consider purchasing the 80usd strike price Calls with
an expiration date of 2026-1-16,
for a premium of approximately $8.50.
If these options prove to be profitable prior to the earnings
Undervalued, Oversold, Overlooked: MRK Hits The Key Zone!Hi all,
Merck & Co. (MRK) is a global pharmaceutical titan and is currently trading near its 52-week low of ~$79. Anchored by Keytruda’s 7% YoY revenue growth, a stable ~4% dividend yield, and an average fair value estimate of $156.59 (98% upside), MRK appears significantly undervalued.
Analysts f
Merck Wave Analysis – 8 April 2025- Merck broke strong support level 81.30
- Likely to fall to support level 75.00
Merck is under bearish pressure after breaking the strong support level 81.30 (the former monthly low from February, which stopped the earlier impulse wave 1).
The breakout of the support level 81.30 should accelerate
Merck & Co. (NYSE: $MRK) Sets Up Q125 Earnings Call for April 24Merck & Co. (NYSE: NYSE:MRK ) will hold its Q1 2025 earnings call on April 24 at 9:00 a.m. ET. Company executives will present financial results and performance updates during the call.
As of April 4th, 2025, MRK closed at $81.47, down $4.92 (5.70%). The stock has declined steadily since peaking at
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050Yield to maturity
7.56%
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061Yield to maturity
7.51%
Maturity date
Dec 10, 2061
US58933YBF1
MERCK & CO. 21/51Yield to maturity
7.41%
Maturity date
Dec 10, 2051
US58933YBA2
MERCK & CO. 20/40Yield to maturity
6.79%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045Yield to maturity
6.63%
Maturity date
Feb 10, 2045
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049Yield to maturity
6.57%
Maturity date
Mar 7, 2049
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042Yield to maturity
6.56%
Maturity date
Sep 15, 2042
US58933YAJ4
MERCK CO. 13/43Yield to maturity
6.44%
Maturity date
May 18, 2043
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063Yield to maturity
6.35%
Maturity date
May 17, 2063
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053Yield to maturity
6.20%
Maturity date
May 17, 2053
MRK5584925
Merck & Co., Inc. 4.9% 17-MAY-2044Yield to maturity
6.11%
Maturity date
May 17, 2044
See all MRKD bonds
Curated watchlists where MRKD is featured.